Remote Monitoring

PA pressure-guided heart failure management is fast becoming the standard of care in NYHA Class III patients. The Cordella Pulmonary Artery Pressure Sensor enables clinicians to remotely monitor and proactively adjust therapy and medications remotely without the need for office visits.

PA pressure-guided heart failure management is fast becoming the standard of care in NYHA Class III patients. The Cordella Pulmonary Artery Pressure Sensor enables clinicians to remotely monitor and proactively adjust therapy and medications remotely without the need for office visits.

News | Heart Failure | March 24, 2021
March 24, 2021 — Endotronix Inc., a digital health and medical technology company working on advancements in treating...
Integrating data from an array of implantable EP devices from different vendors can be difficult or require disconnected silos of data for different vendors. One solution that was recently introduced to integrate data from various vendors is the Optimize EP software, which allows viewing data from all device vendors in one platform to streamline workflows.

Integrating data from an array of implantable EP devices from different vendors can be difficult or require disconnected silos of data for different vendors. One solution that was recently introduced to integrate data from various vendors is the Optimize EP software, which allows viewing data from all device vendors in one platform to streamline workflows.

Feature | EP Lab | March 17, 2021 | By Maninder Bedi, M.D.
A few weeks ago, a patient of mine experienced a cardiac event — his heart stopped. Completely. However, his...
Two examples of hand-held, point-of-care-ultrasound (POCUS) being used to get immediate medical imaging information from patients in underserved areas. Left, a Butterfly Network system using an probe and an app turns a smartphone into an ultrasound system to image a patient at a remote African clinic. Right, a GE vScan being used to image patients in a rural community in Indian as part of an American Society of Echocardiography (ASE) outreach program.

Two examples of hand-held, point-of-care-ultrasound (POCUS) being used to get immediate medical imaging information from patients in underserved areas. Left, a Butterfly Network system using a probe and an app turns a smartphone into an ultrasound system to image a patient at a remote African clinic. Right, a GE vScan being used to image patients in a rural community in Indian as part of an American Society of Echocardiography (ASE) outreach program.

Feature | February 11, 2021 | By Dave Fornell, Editor
There is a lot of talk about health disparities between the insured vs. uninsured, low-income vs. higher-income, rural...
The Optimize EP CaRM software integrates data from several EP devices a patients may use and aggregate it into one location.

The Optimize EP CaRM software integrates data from several EP devices a patients may use and aggregate it into one location. 

News | EP Lab | February 02, 2021
February 2, 2021 – Optimize EP, a digital health company focused on transforming cardiac care by improving the current...
There has been an increasing trend in cardiology to use longer term remote monitoring wearable ECG tracking devices. This is an example of of the Cardiac Insight Cardea Solo adhesive patch device.

There has been an increasing trend in cardiology to use longer term remote monitoring wearable ECG tracking devices. This is an example of of the Cardiac Insight Cardea Solo adhesive patch device.

News | ECG | February 02, 2021
February 2, 2021 — Cardiac Insight, Inc. a healthcare company specializing in wearable cardiac sensors and automated...
The most popular DAIC content in December 2020 included the Boston Scientific Lotus TAVR valve being taken off the market, CMS approving expanding coverage of LVADs for more Medicare patients and numerous COVID-19 related cardiology stories and videos.

The most popular DAIC content in December 2020 included the Boston Scientific Lotus TAVR valve being taken off the market, CMS approving expanding coverage of LVADs for more Medicare patients and numerous COVID-19 related cardiology stories and videos.

Feature | January 05, 2021
January 5, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
With the FDA clearance of the Vital Data Sensor, Biotronik's Biomonitor IIIm features two-in-one detection, providing physicians the ability to monitor for early signs of potential life-threatening cardiac arrhythmias and body temperature increases potentially associated with fever.

With the FDA clearance of the Vital Data Sensor, Biotronik's Biomonitor IIIm features two-in-one detection, providing physicians the ability to monitor for early signs of potential life-threatening cardiac arrhythmias and body temperature increases potentially associated with fever.

News | Implantable Cardiac Monitor (ICM) | December 22, 2020
December 22, 2020 — The U.S. Food and Drug Administration (FDA) cleared Biotronik's Vital Data Sensor, which identifies...
Videos | EP Device Monitoring Systems | December 22, 2020
Robert Kowal, M.D., chief medical officer of the Medtronic cardiac rhythm and heart failure division, said there has...
The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.

The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.

News | Artificial Intelligence | November 24, 2020
November 24, 2020 — The U.S. Food and Drug Administration (FDA) has cleared AliveCor's next generation of interpretive...
Videos | Atrial Fibrillation | November 18, 2020
Steven Lubitz, M.D., MPH, cardiac electrophysiologist, Massachusetts General Hospital, presented the late-breaking...
The Medtronic SEEQ mobile cardiac telemetry system, pictured here, and the Icentia CardioSTAT cardiac rhythm monitoring device both found in reased rates of post-operative atrial fibrillation in the SEARCH-AF trial presented at the American Heart Association annual meeting. #AHA #AHA20 #AHA2020

The Medtronic SEEQ mobile cardiac telemetry system, pictured here, and the Icentia CardioSTAT cardiac rhythm monitoring device both found in reased rates of post-operative atrial fibrillation in the SEARCH-AF trial presented at the American Heart Association annual meeting.

News | Atrial Fibrillation | November 16, 2020
November 16, 2020 — Atrial fibrillation (AF), an irregular heartbeat that can increase the likelihood of stroke, was...
Cardiac monitoring devices range from (left to right) the 12-lead ECG, Holter monitor, patch with snap fasteners, and patch with integrated electronics.

Cardiac monitoring devices range from (left to right) the 12-lead ECG, Holter monitor, patch with snap fasteners, and patch with integrated electronics.

News | Wearables | September 30, 2020
September 30, 2020 — In today’s digital age, focus on digital health and the quantified self have led to the rapid rise...
The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study (Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients). It will evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE. 

The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study to evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE. 

News | Wearables | September 25, 2020
September 25, 2020 — Remote and in-hospital wearable biosensor technology company VitalConnect Inc. has started the...
Fitbit Sense is the company’s first device compatible with an ECG app that enables users to take a spot check reading of their heart that can be analyzed for the heart rhythm irregularity atrial fibrillation (AFib).

Fitbit Sense is the company’s first device compatible with an ECG app that enables users to take a spot check reading of their heart that can be analyzed for the heart rhythm irregularity atrial fibrillation (AFib).

News | Wearables | September 24, 2020
September 24, 2020 — Fitbit received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as...
Selfied might be used with AI to identify patients with heart disease. Getty Images

Getty Images

News | Artificial Intelligence | August 24, 2020
August 24, 2020 — Sending a photo selfie to the doctor could be a cheap and simple way of detecting heart disease using...